Johnson & Johnson

The article explores what guided the decision, which is just the latest example of our Chairman and CEO’s people-first approach to leadership at our healthcare company.

Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.

Check out this infographic breakdown of the company’s first-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.

Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.

The funds will be earmarked for assisting the doctors, nurses, midwives and community health workers who are working tirelessly to treat patients around the world during the novel coronavirus pandemic.

Dr. Dongchen Zhou was a practicing cardiologist in Hangzhou, Zhejiang Province, China, when he received a call to help volunteer at a hospital in Wuhan. In February 2020 he began to treat COVID-19 patients—and recounts for us what his journey was like.

In the 1930s the company commissioned a series of colorful panels to pay homage to men and women who worked at Johnson & Johnson. For Employee Appreciation Day, we tell the story behind the art.

We posed a question to Johnson & Johnson’s Chief Historian: What artifact from the archives do you love best?

Check out this infographic breakdown of the company’s fourth quarter and annual earnings report, with key performance highlights from its pharmaceutical, consumer and medical devices businesses.

Spoiler: It was a giant rooftop electric sign that spread holiday cheer to visitors riding the Pennsylvania Railroad through New Brunswick, New Jersey.